RecruitingNot ApplicableNCT07226960
Deprescribing in Outpatient Internal Medicine Practices
Sponsor
Wake Forest University Health Sciences
Enrollment
100 participants
Start Date
Nov 12, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to evaluate the impact of pharmacist-led medication reviews and deprescribing or de-escalation interventions on reducing the number of medications, falls, and hospitalizations, and improvement in quality of life in geriatric patients.
Eligibility
Min Age: 75 Years
Inclusion Criteria2
- years or older
- taking 6 or more medications
Exclusion Criteria3
- patients in hospice or palliative care
- in Skilled Nursing Facility
- receiving cancer/oncology treatment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALmedication review
Internal medicine providers and PharmDs will identify patients for whom a medication review and potential deprescribing / de-escalation intervention may be beneficial.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07226960